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In previous studies, most researchers tried to ﬁnd predic-
tors to differentiate nondiabetic renal diseases (NDRDs) from
diabetic nephropathy in diabetic patients. As the chronology is
variable, it is not easy to predict NDRDs in patients with
diabetes, especially type 2 diabetes. Absence of retinopathy,
short duration of diabetes, presence of hematuria, and heavy
proteinuria in preserved renal function have been reported as
predictors. These factors can help nephrologists select patients
for kidney biopsy [1].
The renal outcome of NDRDs in diabetic patients is
not clear. Kim et al [2] reported that patients with NDRDs
had better prognosis than those with diabetic nephropathy.
The patients who were treated with immunosuppressants
showed better renal outcomes. These results are similar to
the ﬁndings of a recent study conducted in Korea [3].
However, until now no clinical trials have been conducted
to evaluate the effectiveness of immunosuppressants in
patients with NDRDs. Although immunosuppressants may
have positive renal outcomes, their side effect is not avoidable.
Therefore, the risks and beneﬁts of immunosuppressants
should be considered.Conﬂicts of interest
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In Reply:
We appreciate your interest in our recent article entitled "Non-
diabetic kidney diseases in type 2 diabetic patients." Diabetic
nephropathy is one of the most common causes of end-stage
renal disease in Korea. It is typically diagnosed based on the
clinical history of proteinuria in a patient with diabetes. Renal
biopsy has been recommended for type 2 diabetic patients with
atypical nephropathy because a considerable number of these
patients may have nondiabetic nephropathies [1]. Other causes of
renal disease in diabetes should be considered in the presence of
any of the following circumstances: absence of diabetic retino-
pathy, low or rapidly decreasing glomerular ﬁltration rate, rapidly
increasing proteinuria or nephrotic syndrome, refractory hyper-
tension, presence of active urinary sediment, signs or symptoms
of other systemic diseases, and rapid reduction in glomerular
ﬁltration rate within 2–3 months following the initiation of an
angiotensin-converting enzyme inhibitor or angiotensin receptor
blocker [2].
As Byun et al [3] recently reported, ﬁndings of renal biopsies
from type 2 diabetic patients with renal disease in Korea
showed that these patients comprise a heterogeneous group
of disease entities, some of which are remittable and some
treatable. Our data also revealed various renal diseases in
diabetic patients with nondiabetic nephropathy. Membranous
nephropathy, IgA nephropathy, and acute tubulointerstitial
nephritis were the three most common pathologic ﬁndings.
As you pointed out, it may not be easy to conclude that
renal outcomes of nondiabetic nephropathy are better than
those of diabetic nephropathy because of the heterogeneous
disease entities. In addition, the side effects of intensive
treatment with corticosteroids and/or immunosuppressants
are considerable, although these therapies may have positive
renal outcomes in some patients with NDRDs. Until now, no
clinical trials have been performed evaluating the effectiveness
of immunosuppressants or no clinical practice guidelines have
been established for diabetic patients with nondiabetic glo-
merular diseases. However, it would be important not to miss
a case that is treatable or remittable with corticosteroids
and/or immunosuppressants. I believe that if the beneﬁts of
such intensive treatment outweigh its risks, the treatmentlished by Elsevier. This is an open access article under the CC BY-NC-ND
Letter and Reply / Kidney Res Clin Pract 33 (2014) 68–69 69should be considered in patients with type 2 diabetes having
aggressive NDRDs.Conﬂicts of interest
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